1. Home
  2. VCNX
  3. VCNX News

Latest Vaccinex Inc. (VCNX) News on July 27, 2024

Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024

GlobeNewswire

10 days ago

Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024

Share on Social Networks: